Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Very early researchNot Yet RecruitingNCT07671417What this trial is testingImaging Study in Metastatic Clear Cell RCC.Who this might be right forMetastatic Clear Cell Renal Cell Carcinoma RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT07488533What this trial is testingComparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell CarcinomaWho this might be right forNon-Clear Cell Renal Cell Carcinoma Sun Yat-sen University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712What this trial is testingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerWho this might be right forFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more National Cancer Institute (NCI) 692
Not applicableStudy completedNCT01970267What this trial is testingClear Vision StudyWho this might be right forPosterior Vitreous DetachmentVitreous Floaters University of British Columbia 35
Early research (Phase 1)Study completedNCT05861778What this trial is testingEvaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaSuspected Recurrent Renal Clear Cell CarcinomaRecurrent Renal Cell Cancer Telix Pharmaceuticals (Innovations) Pty Limited 10
Not applicableNot Yet RecruitingNCT07233668What this trial is testingImmediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCCWho this might be right forMetastatic Renal Cell Carcinoma ( mRCC) Seoul National University Hospital 172
Not applicableStudy completedNCT05737290What this trial is testingEffects of Clear Aligners Versus Fixed Appliances on Occlusion After Treatment of Mild Anterior CrowdingWho this might be right forOcclusion Al-Azhar University 12
Not applicableStudy completedNCT05027282What this trial is testingSafety and Effectiveness of the CLEAR + BRILLIANT TOUCH(R) Diode Laser 1440-nm and 1927-nm Combination Wavelength TreatmentWho this might be right forPhotoaging Bausch Health Americas, Inc. 28
Early research (Phase 1)Temporarily pausedNCT06649682What this trial is testing68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCCWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 20
Not applicableStudy completedNCT01107509What this trial is testingPilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of BiomarkersWho this might be right forCarcinoma, Renal Cell St. Joseph's Healthcare Hamilton 20
Early research (Phase 1)Study completedNCT01440998What this trial is testingDasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578025What this trial is testingZanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on ImmunotherapyWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8 City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT01489371What this trial is testingEGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more Gynecologic Oncology Group 16
Not applicableLooking for participantsNCT00001238What this trial is testingVon Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant DisordersWho this might be right forKidney CancerUrologic Malignant DisordersRenal Cell Carcinoma+2 more National Cancer Institute (NCI) 5,000
Testing effectiveness (Phase 2)Study completedNCT00979992What this trial is testingSunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian CancerWho this might be right forOvarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT00004221What this trial is testingCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerWho this might be right forMalignant Ovarian Mixed Epithelial TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more Gynecologic Oncology Group 12
Testing effectiveness (Phase 2)Study completedNCT03680521What this trial is testingNeoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Mirati Therapeutics Inc. 25
Not applicableStudy completedNCT06253052What this trial is testingBenefits of Drinking Clear Fluids Until Called to the Operating Room in Adult Surgical PatientsWho this might be right forAnesthesiaThirst; Due to Deprivation of WaterAspiration Wuerzburg University Hospital 174
Testing effectiveness (Phase 2)Study completedNCT03163667What this trial is testingCB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)Who this might be right forClear Cell Renal Cell Carcinoma Calithera Biosciences, Inc 69